In vitro viability effects on apheresis and buffy-coat derived platelets administered through infusion pumps

References

• Norville R, Hinds P, Wilimas J, Fairclough D, Fischl S, Kunkel K. The effects of infusion methods on platelet count, morphology, and corrected count increment in children with cancer: in vitro and in vivo studies. Oncol Nurs Forum. 1994;21(10):1669–1673.
   PubMedGoogle Scholar
• Snyder EL, Ferri PM, Smith EO, Ezekowitz MD. Use of an electromechanical infusion pump for transfusion of platelet concentrates. Transfusion. 1984;24:524–527.
   PubMed Web of Science ®Google Scholar
• Murray NA, Roberts IA. Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed. 2004 ;89(2):F101–F107.
   Web of Science ®Google Scholar
• Snyder EL, Rinder HM, Napychank P. In vitro and in vivo evaluation of platelet transfusions administered through an electromechanical infusion pump. Am J Clin Pathol. 1990;94(1):77–80.
   PubMed Web of Science ®Google Scholar
• Broos K, De Meyer SF, Feys HB, Vanhoorelbeke K, Deckmyn H. Blood platelet biochemistry. Thromb Res. 2012;129(3):245–249.
   Google Scholar
• Holme S, Sweeney JD, Sawyer S, Elfath MD. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion. 1997;37(1):12–17.
   PubMed Web of Science ®Google Scholar
• Seghatchian J. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apher Sci. 2006;34(1):125–130.
   PubMed Web of Science ®Google Scholar
• Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev. 1997;11(2):130–144.
   PubMed Web of Science ®Google Scholar
• Shanwell A, Wikman A, Ringden O. Pretransfusion incubation of apheresis platelets at 37 degrees C improves posttransfusion recovery. Transfusion. 1992;32(8):715–718.
   Web of Science ®Google Scholar
• Holme S, Heaton WA, Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol. 1987;66(2):233–238.
   Web of Science ®Google Scholar
• Diedrich B, Sandgren P, Jansson B, Gulliksson H, Svensson L, Shanwell A. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang. 2008;94(2):96–102.
   Web of Science ®Google Scholar
• Heuft HG, Goudeva L, Krauter J, Peest D, Buchholz S, Tiede A. Effects of platelet concentrate storage time reduction in patients after blood stem cell transplantation. Vox Sang. 2013;105(1):18–27.
   PubMed Web of Science ®Google Scholar
• Schrezenmeier H, Seifried E. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang. 2010;99(1):1–15.
   Web of Science ®Google Scholar
• Bueno JL, Garcia F, Castro E, Barea L, Gonzalez R. A randomized crossover trial comparing three plateletpheresis machines. Transfusion. 2005;45(8):1373–1381.
   Web of Science ®Google Scholar
• Larsson S, Sandgren P, Sjodin A, Vesterinen M, Gulliksson H. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system. Transfusion. 2005;45(5):743–751.
   Web of Science ®Google Scholar
• Sandgren P, Saeed K. Storage of buffy-coat-derived platelets in additive solution: in vitro effects on platelets of the air bubbles and foam included in the final unit. Blood Transfus. 2011;9(2):182–188.
   Web of Science ®Google Scholar
• Bertolini F, Murphy S. A multicenter evaluation of reproducibility of swirling in platelet concentrates. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. Transfusion. 1994;34(9):796–801.
   Google Scholar
• Moroff G, Eich J, Dabay M. Validation of use of the Nageotte hemocytometer to count low levels of white cells in white cell-reduced platelet components. Transfusion. 1994;34(1):35–38.
   Web of Science ®Google Scholar
• VandenBroeke T, Dumont LJ, Hunter S, et al. Platelet storage solution effects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Vox Sang. 2004;86(3):183–188.
   PubMed Web of Science ®Google Scholar
• Lundin A. Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites. Methods Enzymol. 2000;305:346–370.
   PubMed Web of Science ®Google Scholar
• Vanderlinde RE. Measurement of total lactate dehydrogenase activity. Ann Clin Lab Sci. 1985;15(1):13–31.
   PubMed Web of Science ®Google Scholar
• Sandgren P, Meinke S, Eckert E, Douagi I, Wikman A, Hoglund P. Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES. Transfusion. 2014;54(3):602–612.
   Web of Science ®Google Scholar
• Sandgren P, Stjepanovic A. High-yield platelet units revealed immediate pH decline and delayed mitochondrial dysfunction during storage in 100% plasma as compared with storage in SSP+. Vox Sang. 2012;103(1):55–63.
   Web of Science ®Google Scholar
• Gulliksson H. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev. 2003;17(3):209–215.
   Google Scholar
• Zhang JG, Carter CJ, Culibrk B, et al. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion. 2008;48(5):847–856.
   Web of Science ®Google Scholar
• Apelseth TO, Bruserud O, Wentzel-Larsen T, Bakken AM, Bjorsvik S, Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion. 2007;47(4):653–665.
   PubMedGoogle Scholar
• Apelseth TO, Hervig T. In vitro evaluation of platelet concentrates during storage: platelet counts and markers of platelet destruction. Transfus Apher Sci. 2007;37(3):261–268.
   Web of Science ®Google Scholar
• Fijnheer R, Modderman PW, Veldman H, et al. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion. 1990;30(1):20–25.
   Google Scholar
• Fijnheer R, Pietersz RN, de Korte D, et al. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods. Transfusion. 1990;30(7):634–638.
   PubMed Web of Science ®Google Scholar
• Rock G, Figueredo A. Metabolic changes during platelet storage. Transfusion. 1976;16(6):571–579.
   Web of Science ®Google Scholar
• Cognasse F, Boussoulade F, Chavarin P, et al. Release of potential immunomodulatory factors during platelet storage. Transfusion. 2006;46(7):1184–1189.
   PubMed Web of Science ®Google Scholar
• Fullard JF. The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm Des. 2004;10(14):1567–1576.
   PubMed Web of Science ®Google Scholar
• Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006;108(7):2455–2462.
   PubMed Web of Science ®Google Scholar
• Shattil SJ. Function and regulation of the beta 3 integrins in hemostasis and vascular biology. Thromb Haemost. 1995;74(1):149–155.
   PubMed Web of Science ®Google Scholar
• Holme S, Heaton WA, Courtright M. Platelet storage lesion in second-generation containers: correlation with platelet ATP levels. Vox Sang. 1987;53(4):214–220.
   Google Scholar
• Kilkson H, Holme S, Murphy S. Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood. 1984;64(2):406–414.
   Web of Science ®Google Scholar
• Chavarin P, Cognasse F, Argaud C, et al. In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT blood system). Vox Sang. 2011;100(2):247–249.
   Web of Science ®Google Scholar
• Goodrich RP, Edrich RA, Li J, Seghatchian J. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci. 2006;35(1):5–17.
   PubMed Web of Science ®Google Scholar
• Lin L, Dikeman R, Molini B, et al. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion. 2004;44(10):1496–1504.
   PubMed Web of Science ®Google Scholar
• Sandgren P, Callaert M, Shanwell A, Gulliksson H. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Transfusion. 2008;48(4):688–696.
   Web of Science ®Google Scholar
• Sandgren P, Hild M, Sjodin A, Gulliksson H. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability. Vox Sang. 2010;99(4):341–347.
   Google Scholar
• Sandgren P, Tolksdorf F, Struff WG, Gulliksson H. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-platelets method. Vox Sang. 2011;101(1):35–43.
   Web of Science ®Google Scholar
• Sandgren P, van Waeg G, Verheggen C, Sjodin A, Gulliksson H. Storage of interim platelet units for 18 to 24 hours before pooling: in vitro study. Transfusion. 2011;51(6):1213–1219.
   Google Scholar
• Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion. 2006;46(5):800–810.
   PubMed Web of Science ®Google Scholar
• Chicheportiche Y, Bourdon PR, Xu H, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem. 1997;272(51):32401–32410.
   PubMed Web of Science ®Google Scholar
• Cognasse F, Osselaer JC, Payrat JM, Chavarin P, Corash L, Garraud O. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment. Transfusion. 2008;48(5):809–813.
   Web of Science ®Google Scholar
• Iuliano L, Colavita AR, Leo R, Pratico D, Violi F. Oxygen free radicals and platelet activation. Free Radic Biol Med. 1997;22(6):999–1006.
   PubMed Web of Science ®Google Scholar
• Leo R, Pratico D, Iuliano L, et al. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation. 1997;95(4):885–891.
   PubMed Web of Science ®Google Scholar
• Christensen RD. Advances and controversies in neonatal ICU platelet transfusion practice. Adv Pediatr. 2002;55:255–269.
   Google Scholar
• Holme S. Storage and quality assessment of platelets. Vox Sang. 1998; 74 Suppl 2:207–216.
   Google Scholar
• Berndt MC, Shen Y, Dopheide SM, Gardiner EE, Andrews RK. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost. 2001;86(1):178–188.
   Web of Science ®Google Scholar
• Henrita van Zanten G, Saelman EU, Schut-Hese KM, et al. Platelet adhesion to collagen type IV under flow conditions. Blood. 1996;88(10):3862–3671.
   Web of Science ®Google Scholar
• Falati S, Patil S, Gross PL, et al. Platelet PECAM-1 inhibits thrombus formation in vivo. Blood. 2006;107(2):535–541.
   PubMed Web of Science ®Google Scholar
• Sandgren P, Larsson S, Wai-San P, Aspevall-Diedrich B. The effects of pneumatic tube transport on fresh and stored platelets in additive solution. Blood Transfus. 2014;12(1):85–90.
   Web of Science ®Google Scholar